Measuring levels of synaptic protein NPTX2 in cognitively normal adults may help predict onset of mild cognitive impairment years before symptoms emerge.
Their link with metastases, and thus with aggressive tumors, gives them an advantage over other biomarkers in the early identification of invasive tumors for therapeutic intervention.
Young people with genetic heart disorders predisposing to arrhythmias who are properly treated can engage in e-gaming with very little risk of a cardiac event, researchers say.
Patients who underwent plasma ctDNA testing started therapy for advanced NSCLC earlier than those who underwent only tissue biopsy, but "plasma first does not mean plasma only," the authors say.
Long-term or recurrent antibiotic use during early life was associated with an increased risk of early-onset colorectal cancer and adenomas, according to an analysis of UK Biobank data.